<html style="font-family:Helvetica,Arial,Sans">
<head><title>Summary Statistics</title><style type = "text/css">
p {
font-size:smaller;
}
table {
border: 0px;
border-collapse:collapse;
font-size:smaller;
table-layout:fixed;
margin-left:0%;
margin-right:auto;
}
.headtab {
width: 100%;
margin-left:auto;
margin-right:auto;
}
th {
background-color: #FFFFFF;
font-weight:bold;
text-align:left;
}
table tr:nth-child(odd) td {
background-color: #FFFFFF;
padding:4px;
word-wrap: break-word;
word-break:break-all;
}
table tr:nth-child(even) td {
background-color: #D3D3D3;
padding:4px;
word-wrap: break-word;
word-break:break-all;
}</style></head><body> <table class="headtab"> <tr><td style="text-align:left">sumtable {vtable}</td> <td style="text-align:right">Summary Statistics</td></tr></table> <h1> Summary Statistics </h1><table><tr><th style = "width:22%; text-align:left">Variable</th><th style = "width:11%; text-align:right">N</th><th style = "width:11%; text-align:right">Mean</th><th style = "width:11%; text-align:right">Std. Dev.</th><th style = "width:11%; text-align:right">Min</th><th style = "width:11%; text-align:right">Pctl. 25</th><th style = "width:11%; text-align:right">Pctl. 75</th><th style = "width:11%; text-align:right">Max</th></tr>
| ZISnr | 160 | 236780469 | 75785671 | 106058079 | 172653961 | 313491797 | 323296148 |
| AdmissionNr | 160 | 23379200372 | 563303683 | 22093809531 | 23018444853 | 24019031657 | 24070844535 |
| PatientID | 160 | 6922 | 1931 | 4177 | 5076 | 7962 | 10874 |
| Eligible | 160 | 1 | 0 | 1 | 1 | 1 | 1 |
| Included | 160 | 0.44 | 0.5 | 0 | 0 | 1 | 1 |
| Excluded | 160 | 0.56 | 0.5 | 0 | 0 | 1 | 1 |
| Allocation | 71 | | | | | | |
| ... Baxter | 35 | 49% | | | | | |
| ... Fresenius | 36 | 51% | | | | | |
| MultiFiltrate | 71 | 0 | 0 | 0 | 0 | 0 | 0 |
| Baxter | 71 | 0.49 | 0.5 | 0 | 0 | 1 | 1 |
| Informed consent | 71 | | | | | | |
| ... In orde | 71 | 100% | | | | | |
| Reden exclusie IC geweigerd | 2 | 1 | 0 | 1 | 1 | 1 | 1 |
| Reden exclusie leeftijd | 160 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reden exclusie electrolieten | 160 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reden exclusie hemodynamische shock | 160 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reden exclusie geanticipeerde citraat toxiciteit | 160 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reden exclusie citraat allergie | 160 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reden exclusie voorafgaandelijk RRT | 160 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reden exclusie minder 96h behandeling | 160 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reden exclusie logistiek | 160 | 0 | 0 | 0 | 0 | 0 | 0 |
| Age At Admission | 71 | 63 | 15 | 23 | 53 | 76 | 85 |
| Gender | 71 | | | | | | |
| ... Female | 22 | 31% | | | | | |
| ... Male | 49 | 69% | | | | | |
| Length | 71 | 170 | 23 | 1.9 | 165 | 180 | 195 |
| Weight | 71 | 81 | 18 | 43 | 69 | 90 | 135 |
| LOS before inclusion | 71 | 5.1 | 7.4 | 0.083 | 1.2 | 6.1 | 46 |
| type opname | 71 | | | | | | |
| ... Medical | 44 | 62% | | | | | |
| ... Surgical | 22 | 31% | | | | | |
| ... Trauma | 5 | 7% | | | | | |
| urgentie opname | 71 | | | | | | |
| ... Elective | 13 | 18% | | | | | |
| ... Emergency | 58 | 82% | | | | | |
| infectie bij opname | 71 | | | | | | |
| ... No | 41 | 58% | | | | | |
| ... Yes | 30 | 42% | | | | | |
| Diabetes | 71 | | | | | | |
| ... No | 54 | 76% | | | | | |
| ... Yes | 17 | 24% | | | | | |
| CKD | 71 | | | | | | |
| ... No | 49 | 69% | | | | | |
| ... Yes | 22 | 31% | | | | | |
| COPD | 71 | | | | | | |
| ... No | 60 | 85% | | | | | |
| ... Yes | 11 | 15% | | | | | |
| Arterial Hypertension | 71 | | | | | | |
| ... No | 34 | 48% | | | | | |
| ... Yes | 37 | 52% | | | | | |
| HYpercholesterolemia | 71 | | | | | | |
| ... No | 42 | 59% | | | | | |
| ... Yes | 29 | 41% | | | | | |
| Heart failure | 71 | | | | | | |
| ... No | 57 | 80% | | | | | |
| ... Yes | 14 | 20% | | | | | |
| Liver cirrosis | 71 | | | | | | |
| ... No | 66 | 93% | | | | | |
| ... Yes | 5 | 7% | | | | | |
| Solid cancer | 71 | | | | | | |
| ... No | 60 | 85% | | | | | |
| ... Yes | 11 | 15% | | | | | |
| Hematologic cancer | 71 | | | | | | |
| ... No | 66 | 93% | | | | | |
| ... Yes | 5 | 7% | | | | | |
| ESRD | 71 | | | | | | |
| ... No | 69 | 97% | | | | | |
| ... Yes | 2 | 3% | | | | | |
| Myocardial infarction | 71 | | | | | | |
| ... No | 48 | 68% | | | | | |
| ... Yes | 23 | 32% | | | | | |
| Peripherical vascular disease | 71 | | | | | | |
| ... No | 62 | 87% | | | | | |
| ... Yes | 9 | 13% | | | | | |
| Alcohol | 71 | | | | | | |
| ... No | 55 | 77% | | | | | |
| ... Yes | 16 | 23% | | | | | |
| Drugs | 71 | | | | | | |
| ... No | 70 | 99% | | | | | |
| ... Yes | 1 | 1% | | | | | |
| smoking | 71 | | | | | | |
| ... No | 56 | 79% | | | | | |
| ... Yes | 15 | 21% | | | | | |
| AP2 total | 65 | 30 | 7.9 | 12 | 26 | 35 | 47 |
| SAPS3 total | 70 | 67 | 15 | 36 | 57 | 78 | 94 |
| AP4 total | 65 | 58 | 24 | 3 | 40 | 76 | 96 |
| ICU outcome | 70 | | | | | | |
| ... Alive | 37 | 53% | | | | | |
| ... Dead | 33 | 47% | | | | | |
| Hospital outcome | 70 | | | | | | |
| ... Alive | 34 | 49% | | | | | |
| ... Dead | 36 | 51% | | | | | |
| ...60 | 0 | | | | | | |
| ... No | 0 | | | | | | |
| ... Yes | 0 | | | | | | |
| days invasive MV | 70 | 21 | 20 | 0 | 7.2 | 26 | 100 |
| Invasive Mv before randomizatop, | 70 | 21 | 20 | 0 | 7.2 | 26 | 100 |
| Use of vasopressors before randomizatop, | 70 | | | | | | |
| ... No | 1 | 1% | | | | | |
| ... Yes | 69 | 99% | | | | | |
| AKIN...65 | 70 | 2.8 | 0.59 | -1 | 3 | 3 | 3 |
| AKIN...66 | 70 | 2.2 | 1 | -1 | 2 | 3 | 3 |
| AKIN...67 | 70 | 2.4 | 1.1 | -1 | 2 | 3 | 3 |
| Oliguric AKI | 70 | 0.36 | 0.48 | 0 | 0 | 1 | 1 |